David Rosen – COLL history
- Issuer:
- COLLEGIUM PHARMACEUTICAL INC
- Quarters tracked:
- 16 (Q3 2022 → Q2 2026)
- Current shares:
- 1,279,611
- Current value:
- $46.32M
- Peak shares:
- 3,425,000 (Q2 2023)
- Overall change:
- -62%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 1,279,611 | $46.32M | $36.20 | 0 | 0% |
| Q1 2026 | 1,279,611 | $42.32M | $33.07 | -216,825 | -14% |
| Q4 2025 | 1,496,436 | $69.28M | $46.30 | -1,330,062 | -47% |
| Q3 2025 | 2,826,498 | $98.90M | $34.99 | -331,245 | -10% |
| Q2 2025 | 3,157,743 | $93.37M | $29.57 | +157,743 | +5% |
| Q1 2025 | 3,000,000 | $89.55M | $29.85 | +650,000 | +28% |
| Q4 2024 | 2,350,000 | $67.33M | $28.65 | +1,100,000 | +88% |
| Q3 2024 | 1,250,000 | $48.30M | $38.64 | -1,083,500 | -46% |
| Q2 2024 | 2,333,500 | $75.14M | $32.20 | +499,473 | +27% |
| Q1 2024 | 1,834,027 | $71.20M | $38.82 | -924,226 | -34% |
| Q4 2023 | 2,758,253 | $84.90M | $30.78 | -416,747 | -13% |
| Q3 2023 | 3,175,000 | $70.96M | $22.35 | -250,000 | -7% |
| Q2 2023 | 3,425,000 | $73.60M | $21.49 | +150,832 | +5% |
| Q1 2023 | 3,274,168 | $78.55M | $23.99 | -59,460 | -2% |
| Q4 2022 | 3,333,628 | $77.34M | $23.20 | 0 | 0% |
| Q3 2022 | 3,333,628 | $53.41M | $16.02 | — | NEW |